Lan Coffman
ORCID: 0000-0002-3753-1652
· 10 papers in corpus
2025
Supplementary figures and table
lab-animal
2024
Abstract Endometriosis-associated carcinomas (EACs) and endometrial malignancies have many commonalities yet their pathophysiology, particularly those with high-risk histology such as clear cell, is understudied. EACs are histologically and…
lab-animal
2023
Abstract Introduction: Ovarian clear cell carcinoma (OCCC) is a rare, aggressive, chemo-resistant subtype of epithelial ovarian cancer, and is associated with a significantly worse five-year survival compared to other ovarian cancer types. …
lab-animal
2023
AbstractOvarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem cells …
lab-animal
2023
AbstractOvarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem cells …
lab-animal
2023
Ovarian clear cell cancer (OCCC) is one of the most highly treatment resistant subtypes of epithelial ovarian cancer. OCCC arises within endometriosis, the ectopic growth of endometrial stromal and epithelial cells, thus residing within a u…
2023
Supplementary figures and table
2023
Supplementary figures and table
lab-animal
2022
UNLABELLED: Ovarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem ce…
lab-animal
2021
5561 Background: Endometriosis-associated carcinomas (EACs) such as ovarian clear cell cancer (OCCC) are rare, aggressive, chemo-resistant malignancies. While endometriosis is a known chronic inflammatory condition, the molecular mechanisms…